Buy Cartalax Research Peptide

Sharing the Ala-Glu-Asp tripeptide core with the well-characterised Epithalon tetrapeptide but lacking the C-terminal glycine, Cartalax occupies a structurally informative position within the Khavinson bioregulatory peptide series as a compound associated with cartilaginous tissue research. Also designated Ala-Glu-Asp cartilage tripeptide, has the molecular formula C13H21N3O8 and a molecular weight of 351.32 g/mol. Produced via solid-phase peptide synthesis.

In vitro studies using primary articular chondrocyte cultures have examined whether Cartalax modulates transcription of aggrecan, collagen II and SOX9 genes through promoter-level interactions distinct from those observed with Epithalon. In vivo aged rodent models have explored cartilage tissue transcriptomic profiles following systemic Ala-Glu-Asp cartilage tripeptide administration.

Manufactured in a quality-controlled laboratory to a guaranteed purity of 98% or above. Every batch undergoes independent third-party testing using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature-controlled, monitored cold storage system. A batch-specific Certificate of Analysis is available on request.

Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.